Anchor Bay Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$721K Buy
24,132
+4,167
+21% +$111K 0.38% 69
2026
Q2
$549K Buy
+19,965
New +$522K 0.3% 81

Other funds holding PFE

Anchor Bay Capital's PFE Position: Q3 2026 in Review

Anchor Bay Capital increased its Pfizer (PFE) stake by 21% in Q3 2026, buying an estimated $111K and bringing the position to 24,132 shares worth $721K. The position accounts for 0.38% of the portfolio, ranked #69.

Anchor Bay Capital first reported a position in PFE in Q2 2026 and has held it in 2 quarters since. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Anchor Bay Capital held 24,132 shares of Pfizer worth $721K as of Q3 2026.
  • Anchor Bay Capital bought 4,167 Pfizer shares in Q3 2026, an estimated $111K.
  • Pfizer made up 0.38% of Anchor Bay Capital's portfolio in Q3 2026, its #69 holding.
  • Anchor Bay Capital first reported a position in Pfizer in Q2 2026 and has held it in 2 quarters since.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Anchor Bay Capital's 13F filing for Q3 2026, filed 13 Nov 2026.